| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People/ Culture &GC | Sell | 40,000 | $12.60 | $504,000.00 | -3.2% | +33.5% | +23.7% | |
| Jan 9, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 20,000 | $24.00 | $480,040.00 | -0.8% | +20.1% | -41.0% | |
| Jan 6, 2023 | COO Cooper Companies, Inc. | Lindell Jody S50 | Director | Sell | 1,000 | $344.30 | $344,304.10 | -6.9% | +7.9% | +6.0% | |
| Jan 6, 2023 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Sell | 99,078 | $6.54 | $647,894.22 | -0.8% | -64.9% | -54.8% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 39,507 | $112.25 | $4,434,654.08 | -8.6% | -47.7% | -88.8% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Danziger Asaf61 | Chief Executive Officer | Sell | 212,500 | $108.74 | $23,106,230.11 | -52.2% | -47.7% | -88.8% | |
| Jan 5, 2023 | FEED Envue Medical, Inc. | Mika Thomas | Director | Buy | 50,000 | $0.25 | $12,500.00 | New | -38.6% | -80.4% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Commercial Officer | Sell | 387 | $108.00 | $41,796.00 | -0.5% | -47.7% | -88.8% | |
| Jan 5, 2023 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 5,005 | $1.98 | $9,912.90 | -1.6% | +8.9% | -78.2% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Weinberg Uri72 | Chief Science Officer | Sell | 8,143 | $116.14 | $945,756.00 | -4.3% | -47.7% | -88.8% | |
| Jan 5, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 30,000 | $5.08 | $152,429.76 | -2.9% | -2.2% | -9.6% | |
| Jan 5, 2023 | MXCT Maxcyte, Inc. | Ross Thomas M.82 | EVP, Global Sales &Marketing | Sell | 29,133 | $5.08 | $148,051.08 | -100% | -2.2% | -9.6% | |
| Jan 4, 2023 | INCY Incyte Corp | Stein Steven H55 | EVP &Chief Medical Officer | Sell | 28,399 | $79.78 | $2,265,672.22 | -20.7% | -8.1% | -15.8% | |
| Jan 4, 2023 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 6,751 | $46.38 | $313,122.86 | -7.1% | +7.7% | +25.1% | |
| Jan 4, 2023 | PODD Insulet Corp | Petrovic Shacey56 | Director | Sell | 15,000 | $281.88 | $4,228,200.00 | -50.4% | +14.4% | -28.6% | |
| Jan 4, 2023 | PEN Penumbra Inc | Wilder Thomas57 | Director | Sell | 124 | $223.64 | $27,731.36 | -36.7% | +25.0% | +2.9% | |
| Jan 4, 2023 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 20,000 | $18.11 | $362,255.00 | -1.9% | +8.3% | -15.9% | |
| Jan 4, 2023 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 21,929 | $40.50 | $888,209.92 | -14.6% | -21.0% | +3.4% | |
| Jan 4, 2023 | ARAY Accuray Inc | Pervaiz Ali63 | SVP Chief Financial Officer | Sell | 2,053 | $2.06 | $4,229.18 | -0.5% | +35.2% | +30.5% | |
| Jan 3, 2023 | PEN Penumbra Inc | Sarna Surbhi67 | Director | Sell | 27 | $227.12 | $6,132.24 | -1.4% | +27.4% | +4.7% | |
| Jan 3, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 4,100 | $61.85 | $253,605.00 | -35.0% | +31.6% | +31.1% | |
| Jan 3, 2023 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,500 | $210.07 | $315,105.00 | -1.5% | +4.8% | -20.7% | |
| Jan 3, 2023 | INSP Inspire Medical Systems, Inc. | Ban Randy68 | Chief Commercial Officer | Sell | 10,000 | $252.10 | $2,520,952.60 | -39.2% | -9.9% | -34.7% | |
| Jan 3, 2023 | OM Outset Medical, Inc. | Vazquez Martin84 | Chief Operating Officer | Sell | 5,000 | $26.14 | $130,716.00 | -9.2% | -24.5% | -77.6% | |
| Jan 3, 2023 | INSP Inspire Medical Systems, Inc. | Rondoni John79 | Chief Technology Officer | Sell | 1,170 | $256.00 | $299,520.00 | -7.2% | -9.9% | -34.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.